Meena B. Bansal - Concepedia

Author

Meena B. Bansal

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Gianfranco Alpini, Hongyang Wang, M BANSAL, M Bansal, M. B. Bansal, M. Bansal, M.B. Bansal, MEENA B. BANSAL, MEENA BANSAL, Manu Bansal

134

Publications

7.5K

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai University of California San Diego Pinnacle Clinical Research University of Oxford Inova Health System

About

Meena B. Bansal is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, liver physiology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	3.5K
2	Cell Biology	8	8	638
3	Health Sciences	4	4	781
4	Cellular Physiology	2	2	45
5	Natural Sciences	1	1	58

Meena B. Bansal

Publications

6.3K

Citations

H-Index

Page 1

	Year	Citations
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis Stephen A. Harrison, Pierre Bédossa, Cynthia D. Guy, New England Journal of Medicine	2024	1.4K
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, The Lancet Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease	2019	1.2K
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study Naga Chalasani, Herbert L. Bonkovsky, Robert J. Fontana, Gastroenterology Dilin Prospective StudyHepatologyMedicineLiver PhysiologyGastroenterology	2015	872
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial Stephen A. Harrison, Mustafa R. Bashir, Cynthia D. Guy, The Lancet Metabolic Associated SteatohepatitisHepatologyNonalcoholic Fatty Liver DiseaseLiver PhysiologyPharmacology	2019	733
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection Marc Bourlière, Stuart C. Gordon, Steven L. Flamm, New England Journal of Medicine	2017	558
Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes Rifaat Safadi, M Ohta, Carlos E. Alvarez, Gastroenterology ImmunologyPathologyImmunologic MechanismCirrhosisInflammation	2004	236
Human immunodeficiency virus (HIV)‐1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein‐1 expression Ana C. Tuyama, Feng Hong, Yedidya Saiman, Hepatology	2010	210
Hepatic stellate cells express functional CXCR4 Hong Feng, Ana C. Tuyama, Ting‐Fang Lee, Hepatology	2009	143
Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression Meena B. Bansal, Kellen Kovalovich, Ritu Gupta, Journal of Hepatology InflammationCytokineInterleukin-6 ProtectsLiver PhysiologyImmunology	2005	109
Pathogenesis of MASLD and MASH – role of insulin resistance and lipotoxicity Shalini Bansal, Meena B. Bansal Alimentary Pharmacology & Therapeutics	2024	109

Page 1